BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28928011)

  • 1. Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugs.
    Pantziarka P; Bouche G; Sullivan R; Ilbawi AM; Dare AJ; Meheus L
    Eur J Surg Oncol; 2017 Nov; 43(11):1985-1988. PubMed ID: 28928011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery Outcomes.
    Pantziarka P; Bouche G
    Cancer J; 2019; 25(2):100-105. PubMed ID: 30896531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative events influence cancer recurrence risk after surgery.
    Hiller JG; Perry NJ; Poulogiannis G; Riedel B; Sloan EK
    Nat Rev Clin Oncol; 2018 Apr; 15(4):205-218. PubMed ID: 29283170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding clinical strategies that may impact tumour growth and metastatic spread at the time of cancer surgery.
    Hiller J; Brodner G; Gottschalk A
    Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):427-39. PubMed ID: 24267549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in research related to perioperative cancer care and cancer outcomes.
    Cata JP; Kurz A
    Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):457-64. PubMed ID: 24267551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The perioperative period in cancer surgery: a critical moment! Is there a role for regional anesthesia in preventing cancer recurrence?].
    Beloeil H; Nouette-Gaulain K
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):528-36. PubMed ID: 22465643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer.
    van der Bij GJ; Oosterling SJ; Beelen RH; Meijer S; Coffey JC; van Egmond M
    Ann Surg; 2009 May; 249(5):727-34. PubMed ID: 19387333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of perioperative chemotherapy in patients with resectable colorectal liver metastases].
    Brouquet A; Mitry E; Benoist S
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S1-6. PubMed ID: 20172199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative surgery for local pelvic recurrence of rectal cancer.
    Saito N; Koda K; Takiguchi N; Oda K; Ono M; Sugito M; Kawashima K; Ito M
    Dig Surg; 2003; 20(3):192-9; discussion 200. PubMed ID: 12759498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review.
    Wall T; Sherwin A; Ma D; Buggy DJ
    Br J Anaesth; 2019 Aug; 123(2):135-150. PubMed ID: 31255291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anaesthetic technique and other perioperative factors on cancer recurrence.
    Snyder GL; Greenberg S
    Br J Anaesth; 2010 Aug; 105(2):106-15. PubMed ID: 20627881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current cancer therapies - a guide for perioperative physicians.
    Huitink JM; Teoh WH
    Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):481-92. PubMed ID: 24267553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical and perioperative therapy of liver metastases].
    Schlitt HJ; Arnold D; Knoefel WT; Ridwelski K; Moehler M; Tannapfel A; Reinacher-Schick A
    Onkologie; 2008; 31 Suppl 5():9-13. PubMed ID: 19033698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who should be followed up after transanal endoscopic resection of rectal tumours?
    Speake D; Lees N; McMahon RF; Hill J
    Colorectal Dis; 2008 May; 10(4):330-5. PubMed ID: 18190616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pre- and post-operative chemoradiation therapies for pancreatic cancers].
    Ishikawa O; Ohigashi H; Eguchi H; Yamada T; Sasaki Y; Imaoka S; Nishiyama K
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):182-6. PubMed ID: 16878411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of safe resection margins in tumours of parenchymatous organs].
    Hermanová M; Matěj R; Dušková J; Honsová E; Tichý M
    Rozhl Chir; 2014 Feb; 93(2):100-6. PubMed ID: 24702294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases.
    Bodingbauer M; Tamandl D; Schmid K; Plank C; Schima W; Gruenberger T
    Br J Surg; 2007 Sep; 94(9):1133-8. PubMed ID: 17514637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article.
    Missair A; Cata JP; Votta-Velis G; Johnson M; Borgeat A; Tiouririne M; Gottumukkala V; Buggy D; Vallejo R; Marrero EB; Sessler D; Huntoon MA; Andres J; Casasola OL
    Reg Anesth Pain Med; 2019 Jan; 44(1):13-28. PubMed ID: 30640648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.